The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
Open accessAbstract
Identifying the viral epitopes targeted by broad neutralizing antibodies (NAbs) that sometimes develop in human immunodeficiency virus type 1 (HIV-1)-infected subjects should assist in the design of vaccines to elicit similar responses. Here, we investigated the activities of a panel of 24 broadly neutralizing plasmas from subtype B- and C-infected donors using a series of complementary mapping methods, focusing mostly on JR-FL as a prototype subtype B primary isolate. Adsorption with gp120 immobilized on beads revealed that an often large but variable fraction of plasma neutralization was directed to gp120 and that in some cases, neutralization was largely mediated by CD4 binding site (CD4bs) Abs. The results of a native polyacrylamide gel electrophoresis assay using JR-FL trimers further suggested that half of the subtype B and a smaller fraction of subtype C plasmas contained a significant proportion of NAbs directed to the CD4bs. Anti-gp41 neutralizing activity was detected in several plasmas of both subtypes, but in all but one case, constituted only a minor fraction of the overall neutralization activity. Assessment of the activities of the subtype B plasmas against chimeric HIV-2 viruses bearing various fragments of the membrane proximal external region (MPER) of HIV-1 gp41 revealed mixed patterns, implying that MPER neutralization was not dominated by any single specificity akin to known MPER-specific monoclonal Abs. V3 and 2G12-like NAbs appeared to make little or no contribution to JR-FL neutralization titers. Overall, we observed significant titers of anti-CD4bs NAbs in several plasmas, but approximately two-thirds of the neutralizing activity remained undefined, suggesting the existence of NAbs with specificities unlike any characterized to date.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Self-citationKeele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Self-citationRapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Self-citationEfficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Self-citationMigueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., et al. (2005) · Science · doi:10.1126/science.1111781 · Cited by 744
Self-citationBinley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
Self-citationScanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Salazar-Gonzalez, J. F., Bailes, E., Pham, K. T., Salazar, M. G., Guffey, M. B., Keele, B. F., Derdeyn, C. A., Farmer, P., Hunter, E., Allen, S., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02660-07 · Cited by 596
Self-citationGain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus
Bubić, I., Wagner, M., Krmpotić, A., Saulig, T., Kim, S., Yokoyama, W. M., Jonjić, S., & Koszinowski, U. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7536-7544.2004 · Cited by 569
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1244 · Cited by 502
Roben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., & Burton, D. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4821-4828.1994 · Cited by 455
GP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
Li, Y., Migueles, S. A., Welcher, B., Svehla, K., Phogat, A., Louder, M. K., Wu, X., Shaw, G. M., Connors, M., Wyatt, R. T., et al. (2007) · Nature Medicine · doi:10.1038/nm1624 · Cited by 383
Self-citationLi, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G., Polonis, V. R., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01730-06 · Cited by 359
Self-citationNature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1
Moore, P. L., Crooks, E. T., Porter, L., Zhu, P., Cayanan, C. S., Grise, H., Corcoran, P., Zwick, M. B., Franti, M., Morris, L., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2515-2528.2006 · Cited by 343
Self-citationSattentau, Q. J., & Moore, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.185 · Cited by 334
Moore, J. P., & Sodroski, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1863-1872.1996 · Cited by 304
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
Decker, J. M., Bibollet-Ruche, F., Wei, X., Wang, S., Levy, D. N., Wang, W., Delaporte, E., Peeters, M., Derdeyn, C. A., Allen, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042510 · Cited by 295
Self-citationGao, F., Morrison, S. G., Robertson, D. L., Thornton, C. L., Craig, S., Karlsson, G., Sodroski, J., Morgado, M., Galvao-Castro, B., von Briesen, H., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1651-1667.1996 · Cited by 285
Self-citationMoore, J. P., Cao, Y., Ho, D. D., & Koup, R. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5142-5155.1994 · Cited by 218
Gao, F., Weaver, E. A., Lu, Z., Li, Y., Liao, H.-X., Ma, B., Alam, S. M., Scearce, R. M., Sutherland, L. L., Yu, J.-S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1154-1163.2005 · Cited by 200
Self-citationDhillon, A. K., Donners, H., Pantophlet, R., Johnson, W. E., Decker, J. M., Shaw, G. M., Lee, F.-H., Richman, D. D., Doms, R. W., Vanham, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02749-06 · Cited by 192
Self-citationLiao, H.-X., Sutherland, L. L., Xia, S.-M., Brock, M. E., Scearce, R. M., Vanleeuwen, S., Alam, S. M., McAdams, M., Weaver, E. A., Camacho, Z. T., et al. (2006) · Virology · doi:10.1016/j.virol.2006.04.043 · Cited by 184
Self-citationBinley, J. M., Klasse, P. J., Cao, Y., Jones, I., Markowitz, M., Ho, D. D., & Moore, J. P. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2799-2809.1997 · Cited by 176
Self-citationNelson, J. D., Brunel, F. M., Jensen, R., Crooks, E. T., Cardoso, R. M. F., Wang, M., Hessell, A., Wilson, I. A., Binley, J. M., Dawson, P. E., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02588-06 · Cited by 172
Self-citationIncreased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus Variants
Kolchinsky, P., Kiprilov, E., & Sodroski, J. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2041-2050.2001 · Cited by 171
Li, Y., Svehla, K., Mathy, N. L., Voss, G., Mascola, J. R., & Wyatt, R. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1414-1426.2006 · Cited by 159
Self-citationAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Haynes, B. F., & Montefiori, D. C. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.3.347 · Cited by 155
Self-citationMoore, P. L., Gray, E. S., Choge, I., Ranchobe, N., Mlisana, K. P., Karim, S. S. A., Williamson, C. E., & Morris, L. (2007) · Journal of Virology · doi:10.1128/jvi.02187-07 · Cited by 152
Self-citationSchülke, N., Vesanen, M., Sanders, R. W., Zhu, P., Lu, M., Anselma, D. J., Villa, A. R., Parren, P. W. H. I., Binley, J. Μ., Roux, K. H., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7760-7776.2002 · Cited by 149
Self-citationGórny, M. K., Stamatatos, L., Volsky, B., Revesz, K., Williams, C. A. U., Wang, X., Cohen, S., Staudinger, R., & Zolla‐Pazner, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5232-5237.2005 · Cited by 148
Sharon, M., Kessler, N., Levy, R., Zolla‐Pazner, S., Görlach, M., & Anglister, J. (2003) · Structure · doi:10.1016/s0969-2126(03)00011-x · Cited by 145
Crooks, E. T., Moore, P. L., Franti, M., Cayanan, C. S., Zhu, P., Jiang, P., de Vries, R. P., Wiley, C. L., Zharkikh, I. L., Schülke, N., et al. (2007) · Virology · doi:10.1016/j.virol.2007.04.033 · Cited by 132
Self-citationSuárez, T., Nir, S., Goñi, F. M., Sáez‐Cirión, A., & Nieva, J. L. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01785-3 · Cited by 94
Vaine, M., Wang, S., Crooks, E. T., Jiang, P., Montefiori, D. C., Binley, J. Μ., & Lu, S. (2008) · Journal of Virology · doi:10.1128/jvi.00562-08 · Cited by 79
Self-citationAbrahamyan, L. G., Markosyan, R. M., Moore, J. P., Cohen, F., & Melikyan, G. B. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5829-5836.2003 · Cited by 75
Yang, X., Tomov, V., Kurteva, S., Wang, L., Ren, X., Górny, M. K., Zolla‐Pazner, S., & Sodroski, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12975-12986.2004 · Cited by 69
Pantophlet, R. A., Aguilar-Sino, R. O., Wrin, T., Cavacini, L. A., & Burton, D. R. (2007) · Virology · doi:10.1016/j.virol.2007.03.007 · Cited by 68
Phogat, S. K., Svehla, K., Tang, M., Spadaccini, A., Muller, J., Mascola, J. R., Berkower, I. J., & Wyatt, R. T. (2008) · Virology · doi:10.1016/j.virol.2007.11.005 · Cited by 68
Self-citationCrooks, E. T., Moore, P. L., Richman, D. D., Robinson, J. E., Crooks, J. A., Franti, M., Schülke, N., & Binley, J. Μ. (2006) · Human Antibodies · doi:10.3233/hab-2005-143-407 · Cited by 57
Self-citationHe, Y., Honnen, W. J., Krachmarov, C. P., Burkhart, M. D., Kayman, S. C., Corvalán, J. R. F., & Pinter, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.595 · Cited by 55
Inhibition of HIV‐1 entry by antibodies: potential viral and cellular targets
Phogat, S. K., Wyatt, R. T., & Hedestam, G. B. K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01820.x · Cited by 51
Zwick, M. B., Saphire, E. O., & Burton, D. R. (2004) · Nature Medicine · doi:10.1038/nm0204-133 · Cited by 45
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization
Crooks, E. T., Jiang, P., Franti, M., Wong, S., Zwick, M. B., Hoxie, J. A., Robinson, J. E., Moore, P. L., & Binley, J. Μ. (2008) · Virology · doi:10.1016/j.virol.2008.04.045 · Cited by 41
Self-citationQuakkelaar, E. D., van Alphen, F. P. J., Boeser‐Nunnink, B., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02816-06 · Cited by 31
Cited by
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationStructural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
Self-citationSeaman, M. S., Janes, H., Hawkins, N., Grandpre, L. E., Devoy, C., Giri, A., Coffey, R. T., Harris, L., Wood, B., Daniels, M. G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02108-09 · Cited by 632
Self-citationSimek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00110-09 · Cited by 594
Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies
Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 550
Self-citation
Metadata
- Authors
- Binley, J. M., Lybarger, E. A., Crooks, E. T., Seaman, M. S., Gray, E., Davis, K. L., Decker, J. M., Wycuff, D., Harris, L., Hawkins, N., Wood, B., Nathe, C., Richman, D., Tomaras, G. D., Bibollet-Ruche, F., Robinson, J. E., Morris, L., Shaw, G. M., Montefiori, D. C., & Mascola, J. R.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2008-12
- Volume
- 82
- Issue
- 23
- Pages
- 11651-11668
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2137939749
- Cited by
- 355
- References
- 48
- FWCI
- 15.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.